Evidence map›Paper›PMID 41000867›Full record

ArticlebioRxiv : the preprint server for biology2025

Siglec-F Protects Against Elastase-induced Lung Inflammation and Emphysema in Mice.

Qihua Ye, Naoko Hara, Yan Hu, Marika Orlov, Bradford J Smith, Tonya M Brunetti, Rachel Z Blumhagen, Zhenghui Liu, Bifeng Gao, Melanie Königshoff and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qihua YeDivision of Pulmonary, Allergy and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.ORCID 0000-0002-8037-0225
Naoko HaraDivision of Pulmonary, Allergy and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Yan HuCenter for Perinatal Research, Nationwide Children's Hospital, Columbus, OH, United States.ORCID 0000-0003-0586-6527
Marika OrlovDivision of Pulmonary, Allergy and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.ORCID 0000-0003-1961-0813
Bradford J SmithDepartment of Bioengineering, University of Colorado Denver, Denver | Anschutz Medical Campus, CO, United States.ORCID 0000-0002-1583-6762
Tonya M BrunettiDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.ORCID 0000-0002-2228-2198
Rachel Z BlumhagenCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, United States.ORCID 0000-0001-5949-9561
Zhenghui LiuDivision of Pulmonary, Allergy and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.ORCID 0000-0003-4894-9744
Bifeng GaoDivision of Pulmonary, Allergy and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Melanie KönigshoffCenter for Lung Aging and Regeneration, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.ORCID 0000-0001-9414-5128
William J JanssenDepartment of Medicine, National Jewish Health, Denver, CO, United States.ORCID 0000-0002-6397-3454
Christopher M EvansDivision of Pulmonary, Allergy and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.ORCID 0000-0001-5600-7314

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Targeting early events in MUC5B-driven lung injury and fibrosisP01HL162607 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI David Albert Schwartz · 2023 to 2026
$12.4M
Role of Mucin in Lung Homeostasis and PathophysiologyR01HL080396 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Christopher M Evans · 2009 to 2026
$8.6M
Lung Macrophage Programming in Acute Lung InjuryR35HL140039 · NHLBI · NATIONAL JEWISH HEALTH · PI JANSSEN, WILLIAM · 2018 to 2024
$6.4M
Mechanisms of lung macrophage programming by MUC5B during health and diseaseR01HL130938 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI EVANS, CHRISTOPHER M · 2016 to 2025
$5.2M
Predicting and Preventing Ventilator-Induced Lung InjuryR01HL151630 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SMITH, BRADFORD J · 2021 to 2025
$2.9M
Non-canonical WNT signaling in emphysema and lung regenerationR01HL141380 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOENIGSHOFF, MELANIE · 2019 to 2022
$2.1M
Molecular Analysis of Airway Secretory Cells in Health and DiseaseR00HL161446 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI Yan Hu · 2025 to 2026
$498k
Molecular Analysis of Airway Secretory Cells in Health and DiseaseK99HL161446 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI HU, YAN · 2023 to 2024
$217k
Epithelial Contributions to Lung ImmunityF32HL172725 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ORLOV, MARIKA · 2024 to 2024
$89k
BLRD VA I01 BX005343NCI NIH HHS P30 CA046934NHLBI NIH HHS F32 HL172725NHLBI NIH HHS K99 HL161446NHLBI NIH HHS P01 HL162607NHLBI NIH HHS R00 HL161446NHLBI NIH HHS R01 HL080396NHLBI NIH HHS R01 HL130938NHLBI NIH HHS R01 HL141380NHLBI NIH HHS R01 HL151630NHLBI NIH HHS R35 HL140039
6 · The paper itself

Abstract

Respiratory surfaces are exposed daily to billions of inhaled particles that could cause injury to alveolar tissues where gas exchange occurs. Accordingly, robust defense is essential but must involve minimal physiologic disruption. Airspace macrophages (AMs) protect lung surfaces while also maintaining tissue integrity through non-inflammatory homeostatic responses in health. However, in chronic obstructive pulmonary disease (COPD), AMs contribute to emphysematous alveolar destruction through mechanisms that are poorly understood. We hypothesized that damaging effects of AMs in emphysema result from loss of mechanisms that normally restrain homeostatic AMs. We found that Siglec-F, a common marker of AMs, exerts suppressive effects on tissue resident AMs (RAMs), thereby supporting alveolar integrity in mouse lungs during health and in a model of elastase-induced alveolar destruction. Siglec-F-deficient mice exhibited decreased alveolar numbers at baseline, and they had worsened alveolar damage after elastase challenge that was unexpectedly RAM-mediated. Transcriptomic profiling revealed dysregulation of key pathways involved in tissue remodeling and repair, including extracellular matrix degradation, TGF-β signaling, and phagocytosis. These findings uncover previously unrecognized roles for RAMs and Siglec-F in preserving alveolar integrity. Our findings implicate RAMs and Siglecs as potential therapeutic targets for preserving alveolar integrity in health and for limiting alveolar damage in COPD.

Indexed as

Airspace macrophageEmphysemaInflammationSiglec-F

Identifiers

PMID41000867
PMCPMC12458116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.